Shimokawa; Kenichiro
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shimokawa; Kenichiro.The latest application filed is for "heterocyclic compound".
- Shimokawa; Kenichiro - Kanagawa JP
- SHIMOKAWA; Kenichiro - Fijisawa JP
- Shimokawa; Kenichiro - Nagoya N/A JP
- Shimokawa; Kenichiro - Nagoya-shi JP
| Patent | Date |
|---|---|
| Heterocyclic compound Grant 11,236,099 - Takami , et al. February 1, 2 | 2022-02-01 |
| Heterocyclic Compound App 20220017530 - Takami; Kazuaki ; et al. | 2022-01-20 |
| Substituted pyrrolidine compound and use thereof Grant 11,034,700 - Mikami , et al. June 15, 2 | 2021-06-15 |
| Heterocyclic Compound App 20210139491 - TAKAMI; Kazuaki ; et al. | 2021-05-13 |
| 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor Grant 10,899,752 - Sugimoto , et al. January 26, 2 | 2021-01-26 |
| Substituted Pyrrolidine Compound And Use Thereof App 20200392149 - MIKAMI; Satoshi ; et al. | 2020-12-17 |
| Heterocyclic Compound App 20200163970 - ARIMOTO; Hirokazu ; et al. | 2020-05-28 |
| Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity Grant 10,548,899 - Sugimoto , et al. Fe | 2020-02-04 |
| Heterocyclic compound Grant 10,428,056 - Sugimoto , et al. October 1, 2 | 2019-10-01 |
| 2,3-dihydro-4h-1,3-benzoxazin-4-one Derivatives As Modulators Of Cholinergic Muscarinic M1 Receptor App 20190248776 - SUGIMOTO; Takahiro ; et al. | 2019-08-15 |
| 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor Grant 10,323,027 - Sugimoto , et al. | 2019-06-18 |
| Nitrogen-containing heterocyclic compound Grant 10,208,046 - Sugimoto , et al. Feb | 2019-02-19 |
| Heterocyclic Compound App 20180362516 - SUGIMOTO; Takahiro ; et al. | 2018-12-20 |
| Heterocyclic Compound App 20180303841 - SUGIMOTO; Takahiro ; et al. | 2018-10-25 |
| Heterocyclic compound Grant 10,087,150 - Sugimoto , et al. October 2, 2 | 2018-10-02 |
| 2,3-dihydro-4h-1,3-benzoxazin-4-one Derivatives As Modulators Of Cholinergic Muscarinic M1 Receptor App 20180162850 - SUGIMOTO; Takahiro ; et al. | 2018-06-14 |
| Heterocyclic Compound App 20180050996 - SUGIMOTO; Takahiro ; et al. | 2018-02-22 |
| Heterocyclic compound Grant 9,878,989 - Sugimoto , et al. January 30, 2 | 2018-01-30 |
| Bicyclic heterocyclic compound containing a substituted pyrrole ring Grant 9,777,005 - Sugimoto , et al. October 3, 2 | 2017-10-03 |
| Nitrogen-containing Heterocyclic Compound App 20170081332 - SUGIMOTO; Takahiro ; et al. | 2017-03-23 |
| Heterocyclic Compound App 20160376244 - SUGIMOTO; Takahiro ; et al. | 2016-12-29 |
| Nitrogen-containing Heterocyclic Compound App 20150307497 - SUGIMOTO; Takahiro ; et al. | 2015-10-29 |
| Cyclic heptapeptide and use of the same Grant 8,481,484 - Uemura , et al. July 9, 2 | 2013-07-09 |
| Cyclic Heptapeptide And Use Of The Same App 20100286363 - Uemura; Daisuke ; et al. | 2010-11-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 